Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1444-1448

  Ohtomo, Katsuyuki ^b   Terui, Shoji ^a   Yokoyama, Ryohei ^c   Abe, Hiroyuki ^c   Terauchi, Takashi ^c   Maeda, Go ^c   Beppu, Yasuo ^c   Fukuma, Hisatoshi ^c  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c NONE

Author keywords

osteosarcoma; preoperative chemotherapy; thallium 201 chloride

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FOLINATE CALCIUM; METHOTREXATE; THALLIUM 201;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; SCINTIGRAPHY; TUMOR NECROSIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; FEMALE; FEMORAL NEOPLASMS; HUMANS; MALE; OSTEOSARCOMA; THALLIUM; THALLIUM RADIOISOTOPES;

EID: 0029743760     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Taylor WF, Ivins JC, Pritchard DJ, Dublin DC, Gilchrist GS, Edmonson JH. Trends and variability in survival among patients with osteosarcoma: a 7-yr update. Mayo Clin Proc 1985;60:91-104.
2. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-1606.
3. Goorin AM, Andersen JW. Experience with multiagent chemotherapy for osteosarcoma: improved outcome. Clin Orthop 1991;270:22-28.
4. Rosen G. Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms. Recent Results Cancer Res 1986;103:148-157.
5. Bacci G, Springfield D, Capanna R, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity. Clin Orthop 1987;224:268-276.
6. Winkler K, Beton G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988;6:329-337.
7. Winkler K, Bielack S, Delling G, et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxonibicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Stud COSS-86). Cancer 1990;66:1703-1710.
8. Hudson M, Jaffe MR, Jaffe N, et al. Pediatric osteosarcoma: therapeutic strategies, results and prognostic factors derived from a 10-yr experience. J Clin Oncol 1990;8:1988-1997.
9. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992;10:5-15.
10. Raymond AK, Chawla SP, Carrasco CH, et al. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 1987;4:212-236.
11. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994;12:423-431.
12. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma. Arch Pathol Lab Med 1977;101:14-18.
13. Picci P, Bacci G, Campanacci M, et al. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy: regional mapping of viable and nonviable tumor. Cancer 1985;56:1515-1521.
14. Fletcher BD. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR 1991;157:825-833.
15. Lamki LM. Tissue characterization in nuclear oncology: its time has come. J Nucl Med 1995;36:207-210.
16. Fukuchi M, Tachibana K, Kuwata K, et al. Thallium-201 imaging in thyroid carcinoma: appearance of a lymph-node metastasis. J Nucl Med 1978;19:195-196.
17. 67Ga citrate scintigraphy in the diagnosis of thyroid tumor: concise communication. J Nucl Med 1982;23:225-228.
18. Ochi H, Sawa H, Fukuda T, et al. Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules. Cancer 1982;50:236-240.
19. 201Tl total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 1986;27:1854-1857.
20. Cox PH, Belfer AJ, van der Pompe WB. Thallium-201 chloride uptake in tumors: a possible complication in heart scintigraphy. Br J Radiol 1976;49:767-768.
21. Salvatore M, Carratu L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology 1976;121:487-488.
22. 201Tl-chloride. Clin Nucl Med 1977;2:75-81.
23. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18-23.
24. 201Tl scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993;34:2095-2100.
25. Terui S, Oyamada H, Nishikawa K, Beppu Y, Fukuma H. Thallium-201 chloride scintigraphy for bone tumors and soft part sarcomas [Abstract]. J Nucl Med 1984;25:P114.
26. Ramanna L, Waxman AD, Waxman S, et al. Thallium-201 scintigraphy in bone and soft-tissue sarcoma: evaluation of tumor mass and viability [Abstract]. J Nucl Med 1988;29:854.
27. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with 67Ga and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990;31:567-572.
28. Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. J Bone Joint Surg 1993;75-A:526-531.
29. 201Tl scintigraphy in osteosarcoma: correlation with tumor necrosis after pre-operative chemotherapy. Clin Orthop 1993;293:302-306.
30. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28:47-52.